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Abstract
Purpose Choroidal osteoma (CO) frequently leads
to progressive visual loss due to complications of
secondary choroidal neovascularization (CNV).We
report herein the function of optical coherence
tomography angiography (OCTA) in observation of
CO complicating CNV.
Methods A 25-year-old female presented to our
hospital with chief complaint of sudden unilateral
visual acuity decrease for one week, with metamor-
phopsia in the left eye. Her best corrected visual acuity
was 0.12 in the left eye. Then complete ophthalmo-
logical examinations including fundus photography,
B-scan ultrasound, fundus fluorescent angiography,
and spectral-domain optical coherence tomography
(SD-OCT) were performed. She was diagnosed as CO
on the basis of these results. But the diagnosis could not
explain the sudden visual loss and submacular hyper-
reflective lesion by SD-OCT. Furthermore, she under-
went OCTA and indocyanine green angiography.
Results A diagnosis of classic juxtafoveal CNV
secondary to CO was made eventually. Then she was
treated with an intravitreous injection of ranibizumab
twice. The visual acuity got better and better during
the treatment, and the efficacy was stable, giving rise
to both subjective and anatomic improvement.
Conclusions Optical coherence tomography angiog-
raphy has the advantage of varying the segmentation
and scrolling through the different retinal layers, and
layer-specific observation of blood flow in each layer.
In addition, OCTA can measure the vessel area change
of CNV and provide a better appreciation of CNV,
observing the efficacy more elaboratively and quan-
tizedly. OCTA makes promising noninvasive identi-
fication of the CO-related CNV.
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Background
Choroidal osteoma (CO) is a benign choroidal tumor
which contains mature bone [1]. It is most present in
young healthy females in the second decade of life [2].
Although most cases are asymptomatic, metamor-
phopsia, blurred vision, and visual field defects may be
initial symptoms [3, 4].The prognosis of the tumor is
deteriorated by the presence of choroidal neovascu-
larization (CNV). In this study, we report herein a case
of CO complicating CNV that was specifically diag-
nosed by optical coherence tomography angiography
(OCTA).
Case presentation
A 25-year-old female presented to our hospital with
chief complaint of sudden unilateral visual acuity
decrease for one week, with metamorphopsia in the
left eye. Her best corrected visual acuity was 1.0 in the
right eye and 0.12 in the left eye. Intraocular pressure
was 14 mmHg in the right eye and 16 mmHg in the
left eye. The grade of relative afferent pupil defect
(RAPD) was 3? in the left eye. There was no other
relevant past ocular, medical or family history. She
underwent complete ophthalmological examinations
including fundus photography, B-scan ultrasound,
fundus fluorescent angiography (FFA), and spectral-
domain optical coherence tomography (SD-OCT).
Fundus photography showed peripapillary subretinal
orange and yellow mass, without involvement of
fovea, but accompanied with submacular blood
(Fig. 1a). B-scan ultrasound delineated a high reflec-
tive echo at the posterior pole with shadowing of the
retrobulbar tissues (Fig. 1b). FFA demonstrated peri-
papillary mottled fluorescence, and macular
hypofluorescence, without late staining indicating
the absence of neovascularization (Fig. 1c). SD-OCT
revealed submacular hyperreflective lesion, bulge of
retinal pigment epithelium (RPE), and nasal choroidal
hyperreflectivity (Fig. 1d). She was diagnosed as CO
on the basis of these results. But the results could not
explain the sudden visual loss and submacular hyper-
reflective lesion. In addition, to further confirm, she
underwent indocyanine green angiography (ICGA)
and OCTA. ICGA showed there was a dark area at the
peripapillary with faint hyperfluorescence at the
macular, indicating the presence of CNV (Fig. 1e).
The instrument used in the OCTA was to obtain
amplitude-decorrelated angiography images (software
version: 2015.1.0.90; Optovue, Inc., Fremont, CA,
USA). OCTA (3 mm 9 3 mm) exhibited that there
was abnormal irregular vascular signal in the outer
retina layer and the choriocapillaris layer, and peri-
papillary hyperreflectivity was present in the chorio-
capillaris layer. The osteoma showed no flow in the
choriocapillaris layer. There was vascular morphology
in the RPE bulge on the B-scan OCTA images
corresponding to the abnormal vascular signal in the
angiography (Fig. 1f). A diagnosis of CO complicat-
ing CNV was confirmed eventually. CNV detected in
the region was responsible for the subretinal fluid. And
the flow area of CNV was 0.024 mm2 visible on
OCTA. Then she was treated with an intravitreous
injection of 0.5 mg ranibizumab (Lucentis;
cFig. 1 Ophthalmological examinations of a 25-year-old female
with choroid osteoma complicating choroidal neovasculariza-
tion. Fundus photography a showed peripapillary subretinal
orange and yellowmass (yellow arrow), without involvement of
fovea, but accompanied with submacular blood. B-scan
ultrasound b delineated a high reflective echo at the posterior
pole with shadowing of the retrobulbar tissues. FFA c demon-
strated peripapillary mottled fluorescence (yellow arrow), and
macular hypofluorescence, without late staining indicating the
absence of neovascularization. SD-OCT d revealed submacular
hyperreflectivity, bulge of RPE (yellow arrowhead), and nasal
choroidal hyperreflectivity (yellow arrow). ICGA e showed
there was a dark area at the peripapillary with faint hyperflu-
orescence at the macular (yellow arrowhead). OCTA images of
3 mm 9 3 mm, f exhibited that there was abnormal irregular
vascular signal in the outer retina layer and the choriocapillaris
layer (yellow arrowhead), and peripapillary hyperreflectivity
was present in the choriocapillaris layer. The osteoma showed
no flow in the choriocapillaris layer. There was vascular
morphology in the RPE bulge on the B-scan OCTA images




Genentech, South San Francisco, CA). The risks and
benefits of the intravitreal injection of ranibizumab
were explained to the patient, and written consent was
obtained.
Two weeks after intravitreous injection, she came
back to recheck, and the visual acuity got improved.
Her best corrected visual acuity increased to 0.3, with
a reduction of metamorphopsia in the left eye. SD-
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OCT revealed that submacular hyperreflectivity
decreased, bulge of RPE disappeared, but nasal
choroidal hyperreflectivity sustained. Abnormal vas-
cular signal was absent in the outer retina layer and the
choriocapillaris layer by using OCTA. This patient
was sensitive to ranibizumab. The surgery yielded
favorable outcomes. One month after operation, her
best corrected visual acuity was 0.3 in the left eye. SD-
OCT revealed the absence of submacular hyperreflec-
tivity and discontinuous ellipsoid zone and interdig-
itation zone, without bulge of RPE. OCTA showed
that abnormal vascular signal was absent in the outer
retina layer and the choriocapillaris layer. She was
then performed the second intravitreous injection of
0.5 mg ranibizumab. One month after the second
injection, the patient complained of an evident reduc-
tion of metamorphopsia and the best corrected visual
acuity increased to 0.4 in the left eye. SD-OCT
revealed that discontinuous ellipsoid zone and
interdigitation zone were in regression, without bulge
of RPE. Abnormal vascular signal was not detected by
OCTA. The visual acuity got better and better during
the treatment, and the efficacy was stable, giving rise
to both subjective and anatomic improvement (Fig. 2).
Discussion
In 1978 Gass et al. first described the disease of CO in
four healthy young women with characteristic oph-
thalmoscopy appearance of a slightly elevated, juxta-
papillary, yellowish orange, choroidal lesion with
well-defined margins [5]. CO frequently causes pro-
gressive visual decline as a result of pigment epithelial
decompensation and atrophy of the fovea, or as a result
of complications of secondary CNV [6]. CNV devel-
ops in 47% of CO patients by 10 years and 56% by
20 years, and it is a major cause of visual impairment
Fig. 2 Optical coherence tomography angiography and SD-
OCT for the patient during the follow-up. Two weeks after
intravitreous injection, abnormal vascular signal was absent in
the outer retina layer and the choriocapillaris layer (yellow
arrowhead) by using OCTA. a SD-OCT, d revealed that
submacular hyperreflectivity decreased, bulge of RPE disap-
peared (yellow arrowhead), but nasal choroidal hyperreflectiv-
ity sustained. One month after operation, OCTA showed that
abnormal vascular signal was absent in the outer retina layer and
the choriocapillaris layer (yellow arrowhead). b SD-OCT,
e revealed the absence of submacular hyperreflectivity, and
discontinuous ellipsoid zone and interdigitation zone, without
bulge of RPE. One month after the second injection, abnormal
vascular signal was not detected (yellow arrowhead) by OCTA.
c SD-OCT, f revealed that discontinuous ellipsoid zone and




[2]. When serous retinal detachment is complicated by
CO, it is a recognized association that triggers a search
for possible underlying subretinal neovascularization
[3]. If it was not detected by FFA or OCT, ICGA
should be performed to exclude the subretinal neo-
vascularization. Now we have had a new noninvasive
diagnosis examination to preclude CNV, which is
OCTA.
Optical coherence tomography angiography pro-
vides a high-resolution image of the microvasculature
of the retina at various levels in the retina and choroid
such as superficial capillary plexus, deep capillary
plexus, outer retina, and choriocapillaris in the para-
and peri-foveal areas [7, 8]. The advantage of varying
the segmentation and scrolling through the different
retinal layers, and layer-specific observation of blood
flow in each layer makes OCTA widely used in
clinical. In our patient, the secondary CNV was not
detected during the follow-up. So the change of vessel
area was not observed. We set the layer to the
choriocapillaris level and then operated the moving of
the scan line to detect CNV rigorously. CNV was
detected with OCTA in areas where it was unde-
tectable on the FFA due to the diffuse hyperfluores-
cence. Of note, there have been publications
describing CNV secondary to CO detected by OCTA
[9, 10]. In our study, the CNV showed regression of
lesion size after treatment, same as Szelog et al.
reported [9]. Otherwise, we measured the vessel area
change of CNV, observing the efficacy more elabo-
ratively and quantizedly. Above all, the detection of
CNV secondary to CO is facilitated with OCTA, as the
neovascularization could be covered by osteoma in
dye-based angiography.
The common choroidal tumors misdiagnosed as
CO include choroidal hemangiomas, choroidal mela-
noma, and choroidal metastases. Choroidal haeman-
gioma is a benign vascular tumor, orange in color and
classically located in the macular or paramacular
region of the eye [11]. Associated clinical features are
exudative retinal detachment, macular edema, pig-
mentary changes within the RPE, subretinal fibrosis
over the surface of the lesion, and orange pigment
[12]. Ultrasonography helps to differentiate choroidal
hemangiomas from other choroidal tumors [12].
Choroidal melanoma is suggestive of melanoma such
as greater tumor thickness, the presence of subretinal
fluid and overlying orange pigment, tumor margin
near the optic disk, and the absence of drusen and halo
[13]. OCT generally shows gentle domed shaped,
smooth surface topography with relatively fresh
subretinal fluid demonstrating shaggy photoreceptors
[14]. Choroidal metastases appear as a yellow mass
deep to the retina, often with overlying subretinal fluid
[15].
Conclusions
In the present study, we demonstrate OCTA findings
in patients with CO complicating CNV. It is necessary
to perform noninvasive examinations during the
follow-up to observe the apostasis, replacing the use
of FFA or ICGA. Meanwhile, OCTA can detect the
area change of CNV and provide a better appreciation
of CNV. OCTAmay serve as a marker for patients at a
risk for CNV secondary to CO. And it makes
promising noninvasive identification of the CO-re-
lated CNV. Further study with more number of
patients is still warranted.
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